Metraipolis › archive › dc_eb99c1df7ed9
Cancer-control outcomes of patients with metastatic hormone-sensitive prostate cancer and ≥ 10 bone metastases receiving apalutamide: a real-world cohort — Europe PMC PMID:41772487
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41772487
- DOI
- 10.1186/s12885-[numero omesso]-y
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T10:07:55.350Z
- SHA-256 of the archived text
c9bbb672374cf78e90ad936d0b9867705b0c3342989bf2a14f09be3649a8acab- Stable URL of this page
https://metraipolis.com/documento/dc_eb99c1df7ed9
How to cite
Cancer-control outcomes of patients with metastatic hormone-sensitive prostate cancer and ≥ 10 bone metastases receiving apalutamide: a real-world cohort — Europe PMC PMID:41772487 — Europe PMC (en), https://europepmc.org/article/MED/41772487 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eb99c1df7ed9 (Metraipolis archive dc_eb99c1df7ed9, sha256 c9bbb672374cf78e90ad936d0b9867705b0c3342989bf2a14f09be3649a8acab)
BibTeX
@misc{dceb99c1df7ed9,
title = {Cancer-control outcomes of patients with metastatic hormone-sensitive prostate cancer and ≥ 10 bone metastases receiving apalutamide: a real-world cohort — Europe PMC PMID:41772487},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41772487},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eb99c1df7ed9; sha256 c9bbb672374cf78e90ad936d0b9867705b0c3342989bf2a14f09be3649a8acab},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41772487. Agents can read the archived copy with the MCP tool read_document.